会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Tachykinin peptides, precursor peptides thereof and genes encoding the same
    • 速激肽,其前体肽和编码其的基因
    • US07371810B1
    • 2008-05-13
    • US10048401
    • 2000-07-25
    • Hiroyuki MinakataEiko IwakoshiKyoko Kuroda
    • Hiroyuki MinakataEiko IwakoshiKyoko Kuroda
    • A61K38/00
    • C07K7/22A61K38/00
    • Tachykinin peptide isolated and purified from the posterior salivary gland of the mollusk Octopus vulgaris. The tachykinin peptide provides a new approach for developing medicaments and pesticides through studies on the structural activity correlation at the molecular level, is characterized by: (1) number of amino acid residues is 12; (2) N terminal of the peptide is Lys; (3) an amino acid sequence of 5 amino acids from C-terminal is represented by the following amino acid sequence: Phe-Xaa-Gly-Leu-Met (SEQ ID NO: 6), (wherein, Xaa is Val, lie, Phe or Tyr), especially following amino acid sequences are provided: Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Val-Gly-Leu-Met (SEQ ID NO: 1), Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met (SEQ ID NO: 2).
    • 从软体动物章鱼的后唾液腺分离和纯化速效肽。 速激肽肽通过研究分子水平的结构活性相关性,提供了开发药物和农药的新方法,其特征在于:(1)氨基酸残基数为12; (2)肽的N末端为Lys; (3)来自C末端的5个氨基酸的氨基酸序列由以下氨基酸序列表示:Phe-Xaa-Gly-Leu-Met(SEQ ID NO:6),(其中,Xaa为Val, Phe或Tyr),特别是提供以下氨基酸序列:Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Val-Gly-Leu-Met(SEQ ID NO:1),Lys-Pro-Pro- Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met(SEQ ID NO:2)。
    • 5. 发明申请
    • Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same
    • 新型速激肽,前体肽及其编码基因
    • US20090023184A1
    • 2009-01-22
    • US12099272
    • 2008-04-08
    • Hiroyuki MINAKATAEiko IwakoshiKyoko Kuroda
    • Hiroyuki MINAKATAEiko IwakoshiKyoko Kuroda
    • C12P21/00C12N15/12C12N15/63C12N1/21
    • C07K7/22A61K38/00
    • Tachykinin peptide isolated and purified from the posterior salivary gland Octopus vulgaris which is mollusc. The tachykinin peptide provides a new approach for developing medicaments and pesticides through studies on the structural activity correlation at the molecular level, is characterized by:(1) number of an amino acid resides is 12;(2) N terminal of the peptide is Lys;(3) an amino acid sequence of 5 amino acids from C terminal is represented by the following amino acid sequence (I), —Phe-Xaa-Gly-Leu-Met-NH2  (I), (wherein, Xaa is Val, Ile, Phe or Tyr), especially following amino acid sequence (1) and (2) are provided: H-Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Val-Gly-Leu-Met-NH2  (1) H-Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met-NH2  (2)
    • 从后唾液腺中分离和纯化速效肽,其为软体动物。 速激肽肽通过研究分子水平的结构活性相关性,提供了开发药物和农药的新方法,其特征在于:(1)氨基酸数目为12; (2)肽的N末端为Lys; (3)来自C末端的5个氨基酸的氨基酸序列由以下氨基酸序列(I)表示,<?in-line-formula description =“In-line Formulas”end =“lead”→Phe -Xaa-Gly-Leu-Met-NH 2(I),<β在线公式描述=“内联式”末端=“尾”→(其中,Xaa是Val,Ile,Phe或Tyr) 特别是在提供了氨基酸序列(1)和(2)之后:<?in-line-formula description =“In-line formula”end =“lead”?> H-Lys-Pro-Pro-Ser-Ser-Ser -Glu-Phe-Val-Gly-Leu-Met-NH2(1)<?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In 线型公式“end =”lead“→H-Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met-NH2(2) “直线公式”end =“tail”?>